Express Pharma - Page 895 of 2245 - Express Pharma

Entering pharma drug discovery presents an opportunity to apply scientific capabilities to a new set of health challenges

Biocon secures Yesintek biosimilar rights in nine markets

Government sets up panel to review pharma marketing rules

J&J COVID-19 vaccine trial paused due to unexplained illness in participant

Rhizen Pharma, Curon Biopharma sign exclusive licensing pact to develop and commercialise Tenalisib in Greater China

Innovation – The next frontier

COVID-19 clinical trial disruption declines but trials continue to suffer from slow recruitment

Pharma industry lauds RBI’s decision to discontinue automatic caution listing

Avenue Therapeutics receives complete response letter from the FDA for IV Tramadol

Trodelvy from Immunomedics gets US FDA orphan drug designation for glioblastoma

HitGen to acquire Vernalis for $25 mn in cash

US FDA grants orphan drug designation to oNKord from Glycostem for multiple myeloma

Janssen presents five year data of STELARA in treatment of Crohn’s Disease